11-534332-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005343.4(HRAS):​c.-10C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0458 in 1,607,530 control chromosomes in the GnomAD database, including 1,960 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.037 ( 128 hom., cov: 34)
Exomes 𝑓: 0.047 ( 1832 hom. )

Consequence

HRAS
NM_005343.4 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: -1.01

Publications

15 publications found
Variant links:
Genes affected
HRAS (HGNC:5173): (HRas proto-oncogene, GTPase) This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, cognitive disability, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene. [provided by RefSeq, Jul 2008]
LRRC56 (HGNC:25430): (leucine rich repeat containing 56) Predicted to be involved in cell projection organization. Predicted to be located in cilium. Implicated in primary ciliary dyskinesia 39. [provided by Alliance of Genome Resources, Apr 2022]
LRRC56 Gene-Disease associations (from GenCC):
  • ciliary dyskinesia, primary, 39
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 11-534332-G-A is Benign according to our data. Variant chr11-534332-G-A is described in ClinVar as Benign. ClinVar VariationId is 137556.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0633 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005343.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HRAS
NM_005343.4
MANE Select
c.-10C>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 6NP_005334.1P01112-1
HRAS
NM_176795.5
MANE Plus Clinical
c.-10C>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 6NP_789765.1P01112-2
HRAS
NM_005343.4
MANE Select
c.-10C>T
5_prime_UTR
Exon 2 of 6NP_005334.1P01112-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HRAS
ENST00000311189.8
TSL:1 MANE Select
c.-10C>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 6ENSP00000309845.7P01112-1
HRAS
ENST00000417302.7
TSL:5 MANE Plus Clinical
c.-10C>T
5_prime_UTR_premature_start_codon_gain
Exon 2 of 6ENSP00000388246.1P01112-2
HRAS
ENST00000311189.8
TSL:1 MANE Select
c.-10C>T
5_prime_UTR
Exon 2 of 6ENSP00000309845.7P01112-1

Frequencies

GnomAD3 genomes
AF:
0.0371
AC:
5645
AN:
152194
Hom.:
129
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0179
Gnomad AMI
AF:
0.0407
Gnomad AMR
AF:
0.0378
Gnomad ASJ
AF:
0.104
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0695
Gnomad FIN
AF:
0.0296
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0464
Gnomad OTH
AF:
0.0498
GnomAD2 exomes
AF:
0.0440
AC:
10833
AN:
246070
AF XY:
0.0466
show subpopulations
Gnomad AFR exome
AF:
0.0151
Gnomad AMR exome
AF:
0.0298
Gnomad ASJ exome
AF:
0.0985
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0312
Gnomad NFE exome
AF:
0.0504
Gnomad OTH exome
AF:
0.0511
GnomAD4 exome
AF:
0.0467
AC:
67942
AN:
1455218
Hom.:
1832
Cov.:
32
AF XY:
0.0476
AC XY:
34499
AN XY:
724300
show subpopulations
African (AFR)
AF:
0.0172
AC:
575
AN:
33396
American (AMR)
AF:
0.0322
AC:
1441
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.0994
AC:
2595
AN:
26110
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39678
South Asian (SAS)
AF:
0.0672
AC:
5793
AN:
86160
European-Finnish (FIN)
AF:
0.0313
AC:
1560
AN:
49840
Middle Eastern (MID)
AF:
0.0606
AC:
348
AN:
5746
European-Non Finnish (NFE)
AF:
0.0474
AC:
52557
AN:
1109348
Other (OTH)
AF:
0.0509
AC:
3068
AN:
60250
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
3502
7004
10506
14008
17510
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1968
3936
5904
7872
9840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0370
AC:
5643
AN:
152312
Hom.:
128
Cov.:
34
AF XY:
0.0365
AC XY:
2719
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0179
AC:
743
AN:
41574
American (AMR)
AF:
0.0377
AC:
578
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
361
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.0694
AC:
335
AN:
4828
European-Finnish (FIN)
AF:
0.0296
AC:
315
AN:
10626
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0464
AC:
3156
AN:
68002
Other (OTH)
AF:
0.0492
AC:
104
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
282
563
845
1126
1408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0457
Hom.:
130
Bravo
AF:
0.0371
Asia WGS
AF:
0.0300
AC:
107
AN:
3476

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
2
not provided (3)
-
-
1
Costello syndrome (1)
-
-
1
Noonan syndrome and Noonan-related syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.4
DANN
Benign
0.88
PhyloP100
-1.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41294870; hg19: chr11-534332; COSMIC: COSV54240784; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.